The Oncolytic Times: Oncolytics Biotech News and Information: 2008 AGM

Showing posts with label 2008 AGM. Show all posts

Saturday, May 3, 2008

AGM Webcast

The 2008 Annual and Special Meeting webcast will be held this Wednesday, May 7th at 9:30 am ET. Listen to the webcast here.

About Oncolytics Biotech, Inc.

Oncolytics Biotech Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human cancers. Headquartered in Calgary, Alberta, Canada, the Company was formed in 1998 to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Reolysin, the company's proprietary formulation of the human reovirus, has been demonstrated to replicate specifically in tumour cells bearing an activated Ras pathway. Reolysin may represent a novel treatment for Ras activated tumour cells and some cellular proliferative disorders.
from oncolyticsbiotech.com

Saturday, May 3, 2008

AGM Webcast

Search

Events

About Oncolytics Biotech, Inc.

Links

About Me

Bulletin

Blog Archive

disclaimer